134 related articles for article (PubMed ID: 3718407)
1. [Clinical aspects of acquired antithrombin III deficiency].
von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
[TBL] [Abstract][Full Text] [Related]
2. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
[TBL] [Abstract][Full Text] [Related]
3. [Significance of antithrombin III in kidney diseases].
Schrader J; Köstering H; Scheler F
Behring Inst Mitt; 1986 Feb; (79):216-30. PubMed ID: 3718408
[TBL] [Abstract][Full Text] [Related]
4. Substitution of antithrombin III.
Breddin HK; Kirchmaier CM
Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.
Pabinger I; Schneider B
Thromb Haemost; 1994 May; 71(5):548-52. PubMed ID: 8091378
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
Werner MJ
J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
[TBL] [Abstract][Full Text] [Related]
7. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
8. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
Schramm W
Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of antithrombin III.
Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):276-87. PubMed ID: 6758119
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
[TBL] [Abstract][Full Text] [Related]
11. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
[TBL] [Abstract][Full Text] [Related]
12. [Use of antithrombin III concentrates].
Vinazzer H
Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
[TBL] [Abstract][Full Text] [Related]
13. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
[TBL] [Abstract][Full Text] [Related]
14. [Acquired antithrombin III deficiency].
Müller G
Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombin III in various conditions in internal medicine].
Malý J; Pecka M; Pidrman V; Zadák Z; Gregor J; Jebavý L; Bláha M; Siroký O
Vnitr Lek; 1997 Oct; 43(10):645-8. PubMed ID: 9601877
[TBL] [Abstract][Full Text] [Related]
17. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
Humphries JE
Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
[No Abstract] [Full Text] [Related]
19. [Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].
Gerhards H
Tierarztl Prax; 1987; 15(1):47-55. PubMed ID: 3590168
[TBL] [Abstract][Full Text] [Related]
20. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
